Drug Research & Development
Transforming research into scalable therapeutic solutions
Innovating today, developing
the therapies of tomorrow.
At Biolasta, our commitment to therapeutic innovation drives every aspect of our internal research and development programs. We focus on advancing therapeutics, integrating scientific discovery with practical development strategies to accelerate the journey from early-stage concepts to manufacturing-ready processes. Our R&D approach ensures that every project is data-driven, scalable, and aligned with regulatory standards, allowing promising therapies to progress efficiently and safely.
- Early-Stage Discovery and Candidate Selection
- We design and execute internal R&D programs to identify and optimize novel therapeutic candidates. Feasibility studies evaluate efficacy, safety, and scalability potential. Our work applies cutting-edge technologies for biologics including monoclonal antibodies, recombinant proteins, mRNA, and LNPs as well as non-biologics such as small molecules and advanced formulations.
- Process Development and Scale-Up Planning
- We develop robust upstream and downstream processes for internal candidates and plan scalable production to ensure smooth transition from research to GMP manufacturing. Analytical methods are integrated to support characterization and quality assessment.
- Analytical and Scientific Support
- We provide analytical method development, optimization, and validation to support internal programs. Data analysis, interpretation, and reporting guide development decisions while ensuring alignment of analytical programs with regulatory expectations and development milestones.
- Pipeline Development
- We strategically plan and manage internal therapeutic candidates. Preclinical research is coordinated with manufacturing readiness to enable clinical advancement. Progress is tracked and scientific insights are integrated to accelerate delivery of therapies.
